32088
当前位置: 首页   >  组员介绍   >  王栋梁
王栋梁 2021级复肿核医学科联培博士     进组时间: 2021.9    离组时间: 2024.7

王栋梁,2018年本科毕业于青岛大学医学院,20216月硕士毕业于上海交通大学医学院,20219月进入复旦大学附属肿瘤医院核医学科攻读博士学位。于20219月以联合培养的方式加入本课题组。硕士期间主要研究肿瘤代谢与核医学。目前主要研究方向为肿瘤代谢与分子影像。2024年7月毕业获医学博士学位。2024年8月起入职复旦大学附属肿瘤医院核医学科。

 

Publications:

 1.     Dongliang Wang#, Shuoer Wang#,Mingming Jin, Yan Zuo, Jianpeng Wang, Ya Niu, Qian Zhou, Xiyu Liu, Hang Yu, Wangjun Yan, Huan-Huan Wei, Gang Huang, Shaoli Song*, Shuang Tang*. Hypoxic exosomal circPLEKHM1-mediated crosstalk between tumor cells and macrophages drives lung cancer metastasis. Advanced Science2024 Mar 21:e2309857.  


2.  Wang D, Zhao C, Xu F, Zhang A, Jin M, Zhang K, Liu L, Hua Q, Zhao J, Liu J, Yang H*, Huang G*. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2. Theranostics. 2021 Jan1;11(6):2860-2875.


3.Dongliang Wang#, Shuoer Wang#, Mingming Jin, Yan Zuo , Jianpeng Wang, Ya Niu , Qian Zhou, Jiwei Chen, Xinru Tang, Wenxuan Tang, Xiyu Liu, Hang Yu, Wangjun Yan, Huan-Huan Wei, Gang Huang, Shaoli Song*, Shuang Tang*. Hypoxic Exosomal circPLEKHM1-Mediated Crosstalk between Tumor Cells and Macrophages Drives Lung Cancer Metastasis, Advanced Science,2024 Jun;11(22):e2309857.

4.Dongliang Wang, Chaoshuai Zhao, Fei Xu, Aimi Zhang, Mingming Jin, Kunchi Zhang, Liu Liu, Qian Hua, Jian Zhao, Jianjun Liu, Hao Yang, Gang Huang. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2. Theranostics. 2021 Jan 1;11(6):2860-2875.

5.Yue Wu#, Dongliang Wang#, Yuqing Lou, Xiyu Liu, Pinzheng Huang, Mingming Jin, Gang Huang. Regulatory mechanism of α-hederin upon cisplatin sensibility in NSCLC at safe dose by destroying GSS/GSH/GPX2 axis-mediated glutathione oxidation-reduction system. Biomed Pharmacother. 2022 Jun:150:112927.

6.Shuoer Wang#, Lun Xu#, Dongliang Wang#, Songjiao Zhao, Kun Li, Fen Ma, Qianlan Yao, Yunkui Zhang, Zhiqiang Wu, Yang Shao, Shaoli Song, Wangjun Yan. YTHDF1 promotes the osteolytic bone metastasis of breast cancer via inducing EZH2 and CDH11 translation. Cancer Letters. 2024 Aug 10:597:217047.